<DOC>
	<DOCNO>NCT00260312</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness inactivate poliovirus vaccine vaccine schedule commonly use develop country . The effectiveness inactivate poliovaccine give schedule important national policy maker consider vaccination policy use oral polio vaccine discontinue .</brief_summary>
	<brief_title>Study Inactivated Poliovirus Vaccine Given Earlier Schedule With Shorter Intervals</brief_title>
	<detailed_description>After polio eradication , access live poliovirus highly restrict , oral poliovirus vaccine ( OPV ) use must discontinue . OPV-using country must decide whether switch inactivate poliovirus vaccine ( IPV ) stop polio vaccination . Because limited data available IPV immunogenicity tropical develop country , conduct randomize controlled trial IPV Cuba . The objective study assess humoral mucosal immunogenicity confer IPV administer WHO-EPI schedule ( 6,10,14 wks age ) vs. placebo . A third arm add evaluate immunogenicity IPV administer 2 4 month age . Antibody titer measure prior first dose well 1 month last dose study arm . Target sample size 100 child arm . Mucosal ( intestinal immunity ) measure indirectly assess poliovirus excretion group `` natural challenge '' trivalent oral polio vaccine ( OPV ) recieved study participant participation annual OPV mass campaign approximately 1 month last dose vaccine .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infants bear 18 â€“ 20 week prior first round 2002 National Immunization Days cuba ( March 2002 ) . Born healthy one 4 designate maternity hospital Cuba Serious congenital defect/disease birth</criteria>
	<gender>Male</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>2 Months</maximum_age>
	<verification_date>January 2004</verification_date>
	<keyword>inactived</keyword>
	<keyword>polio</keyword>
	<keyword>vaccine</keyword>
	<keyword>cuba</keyword>
	<keyword>trial</keyword>
	<keyword>randomize</keyword>
	<keyword>eradication</keyword>
</DOC>